EP Patent

EP0088593A2 — 1,2,4-Triazine and pyrazine derivatives

Assigned to Eli Lilly and Co · Expires 1983-09-14 · 43y expired

What this patent protects

This invention relates to certain amino-5,6-diaryl-1,2,4--triazines and -pyrazines useful as activators of GABA and benzodiazepine binding.

USPTO Abstract

This invention relates to certain amino-5,6-diaryl-1,2,4--triazines and -pyrazines useful as activators of GABA and benzodiazepine binding.

Drugs covered by this patent

Patent Metadata

Patent number
EP0088593A2
Jurisdiction
EP
Classification
—
Expires
1983-09-14
Drug substance claim
No
Drug product claim
No
Assignee
Eli Lilly and Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.